Industries > Pharma > Next-Generation Sequencing Market Report 2019-2029

Next-Generation Sequencing Market Report 2019-2029

Drug Discovery, Genetic Screening, Diagnostics, Personalized Medicine, Agriculture and Animal Research, Infectious Diseases, Whole-Genome Sequencing, Targeted Re-Sequencing, Exome Sequencing, RNA Seq, Chip Seq, De Novo Sequencing, Methyl Seq, Instruments, Reagents & Consumables, Services, Hospital & Healthcare Institution, Academics, Biotechnology, Pharmaceutical, Others

PAGES: 189
PRODUCT CODE: PHA0379

DOWNLOAD FREE SAMPLE
WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA0379 Categories: , Tag:

The next generation sequencing market is estimated to have reached $7bn in 2018. Both genetic screening and diagnostic segments dominated the next generation sequencing market in 2018.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Revenue forecast to 2029 of the Global Next Generation Sequencing Market by Application:
• Drug Discovery
• Genetic Screening
• Diagnostics
• Personalized Medicine
• Agriculture and Animal Research
• Infectious Diseases
• Others

Revenue forecast to 2029 of the Global Next Generation Sequencing Market by Technology:
• Whole-Genome Sewuencing
• Targeted Re-Sequencing
• Exome Sequencing
• RNA Seq
• Chip Seq
• De Novo Sequencing
• Methyl Seq
• Others

Revenue forecast to 2029 of the Global Next Generation Sequencing Market by Product:
• Instruments
• Reagents & Consumables
• Services

Revenue forecast to 2029 of the Global Next Generation Sequencing Market by End User:
• Hospital & Healthcare Institution
• Academics
• Biotechnology
• Pharmaceutical
• Others

• Revenue forecast to 2029 of the Global Next Generation Sequencing Market by Regional and National Market:

• North America
• US
• Canada

• Latin America
• Brazil
• Mexico
• Rest of Latin America

• Europe
• Germany
• The UK
• Italy
• France
• Spain
• Russia
• Rest of Europe

• Asia-Pacific
• Japan
• China
• India
• Australia & New Zealand
• ASEAN
• South Korea
• Rest of Asia-Pacific

• MEA
• GCC Countries
• Israel
• Rest of Middle East

• Africa
• South Africa
• Central Africa
• North Africa

Each regional market is further segmented by submarkets.

The report also includes profiles and for some of the leading companies in the Next Generation Sequencing market, with a focus on this segment of these companies’ operations:
Agilent Technologies, Inc.
BGI (Beijing Genomics Institute)
Eurofins Scientific
F. Hoffmann-La Roche AG
Illumina, Inc
Macrogen, Inc
Oxford Nanopore Technologies, Ltd
Pacific Biosciences of California, Inc.
PerkinElmer, Inc.
Qiagen N.V.
Thermo Fisher Scientific Inc

Buy our report today Next-Generation Sequencing Market Forecast 2019-2029: Drug Discovery, Genetic Screening, Diagnostics, Personalized Medicine, Agriculture and Animal Research, Infectious Diseases, Whole-Genome Sequencing, Targeted Re-Sequencing, Exome Sequencing, RNA Seq, Chip Seq, De Novo Sequencing, Methyl Seq, Instruments, Reagents & Consumables, Services, Hospital & Healthcare Institution, Academics, Biotechnology, Pharmaceutical, Others. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Next-Generation Sequencing Market Report 2019-2029

    Download sample pages

    Complete the form below to download your free sample pages for Next-Generation Sequencing Market Report 2019-2029

      Latest Pharma news

      Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034

      The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.

      23 April 2024

      READ

      Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

      The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

      18 April 2024

      READ

      Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

      The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

      17 April 2024

      READ

      Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

      The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

      12 April 2024

      READ